Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone: A Jordanian Cohort Study.

Autor: Al-Mistarehi AW; School of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA., El-Akawi S; Internal Medicine, MedStar Washington Hospital Center-Georgetown University, Washington, DC, USA., Kheirallah KA; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR., Bani Ata EM; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR., Zaitoun KJ; Faculty of Medicine, Jordan University of Science and Technology, Amman, JOR., Khassawneh AB; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR., Jarrah A; Internal Medicine, Detroit Medical Center/Sinai Grace Hospital/Wayne State University, Detroit, USA., Alzoubi HM; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR., Al-Azzam S; Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, JOR., Karasneh RA; Faculty of Medicine, Yarmouk University, Irbid, JOR., Altawalbeh RB; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR., Khassawneh B; Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR.

Publikováno v: Cureus [Cureus] 2024 Aug 22; Vol. 16 (8), pp. e67467. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).